Listed

ICU Medical Inc: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 10, 2019 and accepted by EDGAR at May 10, 2019, 16:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$330.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-01-01 to 2019-03-31$195.6mus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31$135.3mus-gaap:GrossProfit
Research and development3 months2019-01-01 to 2019-03-31$12.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-01-01 to 2019-03-31$72.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-01-01 to 2019-03-31$30.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$133.0kus-gaap:InterestExpense
Income tax3 months2019-01-01 to 2019-03-31$2.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-01-01 to 2019-03-31$31.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31$1.44us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-01-01 to 2019-03-31$1.51us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-01-01 to 2019-03-3121,551,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2019-01-01 to 2019-03-31−$21.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2019-01-01 to 2019-03-31$28.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-03-31$296.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$920.5mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$1.61bnus-gaap:Assets
Current liabilitiesAt period end2019-03-31$238.4mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2019-03-31$1.28bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000883984-19-000017. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.